| AUC | Areas under the curve |
| ANRIL | Antisense ncRNA in the INK4 locus |
| Bcl-2 | B-cell lymphoma 2 |
| CAD | Coronary artery disease |
| CDC42 | Cell division control protein 42 |
| CHD | Coronary heart disease |
| EAP | Extrinsic apoptosis pathway |
| EVs | Extracellular vesicles |
| EZH | Enhancer of zeste homologue |
| FRS | Fibroblast growth factor receptor substrate |
| GSH-PX | Glutathione peroxidase/reductase |
| HASMCs | Human aortic smooth muscle cells |
| HDAC | Histone deacetylase |
| HIFs | Hypoxia-inducible factors |
| IAP | Intrinsic apoptosis pathway |
| IHD | Ischaemic heart disease |
| IL | Interleukin |
| JAK | Janus kinase |
| LDL | Low-density lipoprotein |
| LINC01220 | Long intergenic non-protein coding RNA 1220 |
| lncRNA | Long non-coding RNA |
| MALAT1 | Metastasis-associated lung adenocarcinoma transcript 1 |
| MI | Myocardial infarction |
| MIAT | MI-associated transcript |
| MMECs | Muscle microvascular endothelial cells |
| ncRNA | Non-coding RNA |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| oxLDL | Oxidised LDL |
| PCD | Programmed cell death |
| PCI | Percutaneous coronary intervention |
| PI3K/AKT | Phosphatidylinositol 3-kinase/protein kinase B |
| PRC | Polycomb repressive complex |
| PRX/Trx | Peroxiredoxin/thioredoxin |
| RISC | RNA-induced silencing complex |
| ROS | Reactive oxygen species |
| SERCA2a | Sarcoplasmic/endoplasmic reticulum Ca2+-ATPase |
| SLC8A1 | Solute carrier family 8 member A1 |
| STAT | Signal transducer and activator of transcription |
| STEMI | ST-segment elevation MI |
| TNF-α | Tumour necrosis factor alpha |
| VEGF | Vascular endothelial growth factor |
| VSMCs | Vascular smooth muscle cells |